Get the full Synaps company profile
Access contacts, investors, buying signals & more
Architectural design in the AI era just got a $3.6M boost, as Synaps announced its pre-seed funding round. The startup is building a radically new design platform where ideas move at the speed of thought, making architectural design fluid, playful, and fast, all within a browser.
The capital, secured from investors Plug and Play Tech Center and Fil Rouge Capital, will support Synaps' mission to enhance imagination with AI instead of replacing it, from sketch to floor plan, facade to render.
Some journeys you don't just watch — you get to walk some small parts of it alongside them. Dear Brendon A., Kevin Cobaj, and Agron Bajraktari, dear Synaps – congratulations on raising $3.6M pre-seed. 🎉 But honestly? The round is just the headline. The real story is what happened before it.
The late nights refining the product. The discipline to ship, iterate, and stay focused, seeing you working 24/7 when you were part of our Program last year. The courage to launch last year in Tirana in front of some of the world's most renowned architects – and deliver. 60,000 users and hundreds of paying customers later, still in beta, before the full product is even out. Synaps is building wha
Epitome Therapeutics
Epitome Therapeutics is a biotechnology company advancing precision epigenome editing for programmable gene expression. Founded in 2025 as a spin-off from EMBL, Epitome is developing CADENCE, a next-generation platform designed to enable the precise and durable calibration of gene dosage without altering the underlying DNA sequence. The company aims to establish new therapeutic approaches for diseases driven by dysregulated gene activity, including rare and metabolic disorders.
$2.3M Pre-seed
24 days ago
Loom Ventures
We invest in European early-stage companies that make infrastructure more autonomous, capable, and resilient. STRABAG, one of Europe's largest infrastructure groups, is our investor and partner. This gives us and our founders direct industry access and domain expertise.
$108.0M Unknown
25 days ago
Largest funding rounds in Architecture on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  liminal | Unknown | $2.0B | 1y ago |
| 2 |  ADEPT Denmark | Unknown | $1.0B | 1y ago |
Companies that recently closed a Pre-seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Quarki technologies | Pre-seed | $220.0K | today |
| 2 |  Finley United States | Pre-seed | $1.9M | today |
Mobius Bio
Mobius is a discovery stage biotech utilising a unique, clinically validated platform to identify and develop novel anticancer drugs. Our vision is to systematically go beyond the mouse and discover molecules rooted in a deep understanding of human biology, not animal models, to deliver medicines designed to succeed in the clinic. We do this by integrating frontier AI capabilities, deep disease insights and a proprietary wet lab platform, which allows us to interrogate disease mechanisms directly in live human tissue samples with proven clinical relevance. We are an international team of dedicated drug hunters, engineers and entrepreneurs determined to bring transformative treatments to patients with high unmet medical needs.
$30.0M Unknown
27 days ago
| 3 |  Egis France | Unknown | €1.0B | 1y ago |
| 4 |  SNAP | Unknown | $700.0M | 1y ago |
| 5 | ADEPT Denmark | Unknown | $350.0M | 1y ago |
| 3 |
 Strattum AI Brazil |
| Pre-seed |
| $3.2M |
| today |
| 4 |  KushoAI United States | Pre-seed | $600.0K | today |
| 5 |  Lane Canada | Pre-seed | $1.0M | 1d ago |
Contacts, investors, buying intent signals & tech stack.
Trusted by 200+ sales teams
Plug and Play Tech Center
Fil Rouge Capital
VC
Reach Synaps's investors directly from your dashboard.
Start free trialUnlock 3 more key decision-makers at Synaps with verified emails and LinkedIn.
Start free trial
Crush Security
Recently received
Dex
Recently received
SPREAD AI
Recently received
